| EKSO BIONICS |
| USA |
| Gesundheit |
| US2826444000 / A4197U |
| 23E0 (Frankfurt) / EKSO (NASDAQ) |
| FRA:23E0, ETR:23E0, 23E0:GR, NASDAQ:EKSO |
| - |
| https://eksobionics.com/ |
|
Ekso Bionics Holdings, Inc. is a pioneering robotics company specializing in the development and commercialization of powered exoskeletons, wearable robotic devices designed to enhance human mobility, strength, and endurance. Founded in 2005, Ekso Bi..
>Volltext.. |
| 32.81 Mio. EUR |
| 35.82 Mio. EUR |
| 11.07 Mio. EUR |
| -10.16 Mio. EUR |
| -10.11 Mio. EUR |
| -4.38 EUR |
| 4.02 Mio. EUR |
| 1.01 Mio. EUR |
| -10.2 Mio. EUR |
| 0.14 |
| -28.6% |
| -3.22% |
| - |
| - |
| - |
| EKSO BIONICS, EKSO BIONIC |
| 02.04.26 |
|
||||
|